The new coronovirus vaccine may be the biggest political gamble of our generation, but it also marks a crucial moment in Canada’s history.
The country’s first ever vaccine trial has begun in B.C., and the results have already been seen by millions of Canadians.
Here’s a look at how the vaccine has changed the way the country thinks about vaccination.
1 of 7 i View slideshow The Globe and Mail’s special coverage on Canada’s coronaviruses will take place from June 9 to June 16.
Story continues below advertisementThe vaccine trials have started in B, but they’re just the beginning of what’s to come in the province.
Here are some key developments:The vaccine trial will cover all doses of the vaccine, which includes a three-dose regimen and a two-dose booster.
This means that all Canadians will receive a three dose regimen of the vaccines vaccine, with the first dose administered on May 17, the second on June 9 and the third on June 16, as per schedule.
It also means that the first shot of the three-pack will have a chance to spread out over three months.
After that, the first vaccine dose will be administered on July 22, followed by the second shot on August 15 and the final shot on September 13.
The third shot is not yet scheduled.
The first trial of the new vaccine will be in Alberta, and the trial will involve more than 400 people.
As we reported, the vaccine trial is expected to take up to two months.
Here is a quick look at what the vaccine will look like in practice:The final dose of the two-pack vaccine, however, will be available on the same day as the trial.
This means that most Canadians will be able to get a shot at that point.
In addition to the three dose trials, the new vaccines will be distributed to the general population through a two week trial in June.
A two-week trial is also planned for B.A. and New Brunswick, but the trials will be more limited in scope.
The trials will also include a small population in Alberta.
Finally, the trials are expected to run from July 16 to September 13, and that means that some people will be allowed to participate in the trials as early as June 13.
Here are some of the key points of the trial:The first phase of the trials is intended to test the efficacy of the first and second dose, respectively, of the one-dose vaccine.
This is important because the two doses are designed to protect people against three distinct viruses.
The first vaccination trial will also focus on people who already had a previous vaccination.
This could mean that some individuals who were already vaccinated for the virus may still be eligible for the new version of the shot.
In the first phase, the two vaccines will start out in the same doses as the first, but then they will be adjusted to make them less effective in certain settings, and will eventually be switched to a two dose regimen.
This allows people to receive the two shots at different times of the day, so that they are protected from the virus when they are not in a group.
The second phase will also test the effectiveness of the second and third doses, as well as the effectiveness and safety of the pre-exposure prophylaxis (PrEP) vaccine.
Because the second dose of a vaccine is designed to be given once, the PrEP vaccine is only effective for a few weeks, so those who receive the first or second dose should take the second one.
Additionally, the trial is set to run through September 13 to ensure that the vaccine is safe for all Canadians.
All of the participants will be given a second dose on the following day, but there is a catch: They will not get their first shot until three weeks later.
If a participant has a high-risk infection, or has had the vaccine at some point before, they may still need to wait until three months to get their second shot.
And if you’re one of the unlucky few who have a low-risk partner, you may need to take your first shot at least three weeks before you get your second.
If you have to take the vaccine three weeks in advance of the start of the phase, you can still receive the second vaccine as soon as three weeks after you get the first.
But if you are taking the vaccine before the start, you won’t receive the shot until two weeks later, and you’ll have to wait a month for your second shot to be administered.
The trial will continue for the next two weeks, and it will end on October 3, when all of the vaccinated people will have had a chance at receiving their vaccine doses.
To date, around 20,000 people have already participated in the trial, with around 4,000 of those people receiving the second vaccination.
At the end of the year, if the trial shows a good outcome, the government